
President Biden on Thursday signed an executive order to back up Centers for Disease Control and Prevention (CDC) guidelines recommending that international travelers quarantine for seven days after arriving in the …

President Biden on Thursday signed an executive order to back up Centers for Disease Control and Prevention (CDC) guidelines recommending that international travelers quarantine for seven days after arriving in the …

The one-day clinic has a goal of administering 2,000 vaccines to eligible members of the public in the Seattle area.
A new wearable device may help people with inflammatory bowel disease, more quickly predict when flare-ups will occur, a study presented Thursday during the Crohn’s & Colitis Congress found.
A dip in the vaccines’ effectiveness would be “all the more reason why we should be vaccinating as many people as you possibly can,” Fauci added. Source: Dr. Fauci says Covid vaccines appear to be less effective against some new strains

Associated Press
ISTANBUL — A devoted dog has spent days waiting outside a hospital in northern Turkey where her sick owner was receiving treatment.
The pet, Boncuk (Bon-DJUK), which means bead, followed the ambulance that transported her owner, Cemal Senturk, to hospital in the Black Sea city of Trabzon on Jan. 14. She then made daily visits to the facility, private news agency DHA reported on Wednesday.
Senturk’s daughter, Aynur Egeli, said she would take Boncuk home but the dog would repeatedly run off and return to the hospital.
Hospital security guard Muhammet Akdeniz told DHA: “She comes every day around 9 a.m. and waits until nightfall. She doesn’t go in.”
“When the door opens she pokes her head inside,” he said.
On Wednesday, Boncuk was finally reunited with Senturk when he was pushed outside in a wheelchair for a brief meeting with his dog.
“She’s very used to me. And I miss her, too, constantly,” he told DHA.
Senturk was discharged from the hospital later on Wednesday and returned home with Boncuk.
mask up, wash up and stay clear and safe

By Madeline Holcombe | CNN
The United States could face as many as 100,000 more Covid-19 deaths in less than a month, according to the US Centers for Disease Control and Prevention.
The nation reported more than 4,000 Covid-19 deaths Wednesday, only the third day ever to cross that threshold, bringing the death toll to at least 406,001 people, according to the Johns Hopkins University tracking data.
And by February 13, that number could reach 508,000, according to an ensemble forecast published by the CDC. The last forecast, on January 13, projected up to 477,000 deaths by February 6.
The CDC’s ensemble forecast comes as the US on Thursday marks one year since the first patient with Covid-19 was identified in the US — a number that has since ballooned to more than 24.4 million, per Johns Hopkins.
While the US is far from out of the woods, CNN analysis of Johns Hopkins data shows slight dips in new daily cases.
New cases are down 21% compared to last week, the largest week-over-week drop since the pandemic began. As of Wednesday the average number of new cases over the last seven days remained high, at 194,252 — but that marked a dip below the 200,000 per day average the country has consistently seen for weeks.
As of Thursday morning, 43 states were reporting decreases in new Covid-19 cases greater than 10% compared to last week, according to CNN’s analysis.
Six states — Maine, New Hampshire, New Jersey, South Carolina, Texas and Vermont — were holding steady compared to the week prior. Only Virginia showed an upward trend in cases greater than 10% compared to last week.
And according to data from the COVID Tracking Project, the US has a 9.81% positivity rate over the last seven days, dropping below the 10% threshold for the first time since late November.
Biden team tackles Covid-19
President Joe Biden is taking steps to recalibrate the country’s response to the virus, with an emphasis on vaccine distribution. There remain significant challenges with vaccine supply across the country, according to state officials. And sources tell CNN that Biden and his advisers are inheriting no coronavirus vaccine distribution plan from the outgoing Trump administration.
New CDC director Dr. Rochelle Walensky on Thursday told NBC News the agency was working with the federal government’s Operation Warp Speed, vaccine manufacturers and the states to understand the supply issues.
But in the meantime, “right now, I think we still have vaccine on the shelves that we need to get into people,” she said. Federal officials are looking at a “diverse” rollout plan, she said, involving community vaccination centers, stadiums and mobile units to get vaccines to everyone across the country.
Dr. Anthony Fauci, the nation’s top infectious disease expert and Biden’s chief medical adviser, said the United States can reach the President’s goal of 100 million shots in 100 days — and may even be able to surpass it.”
“The President has made this his top priority,” Fauci told ABC’s “Good Morning America,” adding he was set to meet with Biden later Thursday to brief him on Covid-19 and vaccine distribution.
“As he says, he’s going to do everything that he needs to do to make sure we have a successful rollout of the vaccines, get it into people’s arms and get as many people vaccinated as we possibly can,” Fauci said.
Biden also announced the US would rejoin the World Health Organization, a move Fauci said was important for an effective global response.
“The official announcement that we are rejoining, we’re going to live up to our financial commitments and a whole bunch of other things, it was really a very good day,” Fauci said. “The response I’m getting from my colleagues all over the world is really very, very refreshing.”
California deaths and severity of cases remain high
Most coronavirus metrics have been improving in California, an epicenter of the virus in the US. But the severity of cases in the state and the death toll remain high.
California added 22,403 new cases Wednesday, which is well below the average daily number for the state of 38,000.
But it also reported 694 new Covid-19-related deaths Wednesday, the second-highest single-day toll to date. The previous high of 708 was recorded nearly two weeks ago.
In Los Angeles, the rate of death among hospitalized Covid-19 patients has nearly doubled in recent months.
Since November, hospitalized patients in Los Angeles County have had about a 23% chance of dying from the disease, health officials said Wednesday. That rate marks a significant increase from the prior three months when Covid-19 patients had an approximately 12% chance of dying, according to the county’s Department of Health Services.
Along with the fatality rate, the length of hospital stays for coronavirus in Los Angeles County jumped from about seven days between September and November to about nine and a half from November to January, suggesting the severity of illness in those hospitalized has jumped, LADHS said.
“This trend does not mean the virus has become more virulent or that care in hospitals worsened during the surge,” Health Services Director Christina Ghaly explained. “Rather, we believe these trends are because hospitals, facing capacity constraints in the setting of the surge, became more selective in determining which patients to admit.
“In other words, hospitals are discharging more of the lower-acuity patients home with oxygen. They are admitting only the most critically ill patients.”
But with a limited supply of coronavirus vaccine, state epidemiologist Erica Pan said it may take four to five months to get all Californians over the age of 65 vaccinated.
‘A constant pattern of basically running out’ of vaccine
The push to get people vaccinated has grown as officials race to distribute doses to meet their demand.
As of Wednesday, more than 16.5 million doses have been administered in the US and nearly 2.2 million Americans are fully vaccinated, the CDC said.
New York Gov. Andrew Cuomo said the state is administering about 65,000 doses a day — a rate that will deplete its current supply in two or three days. “What’s clear now is that we will be going from week to week and you will see a constant pattern of basically running out, waiting for the next week’s allocation and then starting up again,” Cuomo said.
The state will receive 250,400 doses next week, but Cuomo urged Biden to increase the supply to states immediately.
Top 3 mortgage approval obstacles in the COVID-19 pandemic
Despite reactions, California says Moderna’s COVID vaccine is safe to use
Coronavirus: California passed 3 million cases, 34,000 deaths on Jan. 19
Coronavirus: 6,492 new cases, 262 deaths reported in Los Angeles County on Jan. 20
Medical consultant presents options for independent health department to West Covina City Council
“At this current rate of supply, it takes seven and a half months to get enough vaccine for the currently eligible population,” Cuomo said.
Wisconsin Gov. Tony Evers issued a statewide mask mandate on Tuesday while the state waited for more vaccine doses.
“At the end of the day, vaccine supplies are limited, so while we continue to ask the federal government for more vaccines and faster, we have to keep working together to stop the spread today,” Evers said, “by continuing to wear our masks, staying home whenever we can, avoiding gatherings, and doubling down on our efforts to keep our friends, neighbors, and families safe.”

Mutation of SARS-CoV2 – current variants of concern – EN –
#15,734
The #1 question on everyone’s mind is how much of a threat do the three recently emerged variants pose to the pandemic response. Already we are seeing nations move to limit international travel, and increase lockdowns, in hopes of slowing their spread.
While there is still much we don’t know about how these variants will behave – in terms of enhanced transmission, reinfection risks, and susceptibility to our current vaccines – the ECDC has published an update to their initial assessment published on December 29th.
The ECDC has raised their risk assessment to High/Very High based primarily on the enhanced transmissibility of these variants. They acknowledge significant knowledge gaps regarding these three variants in the following excerpt from the report.
Knowledge gaps
There are currently many uncertainties and knowledge gaps related to the impact of the VOC 202012/01 or other variants (i.e. 501Y.V2 and lineage P.1), including the extent of geographical spread across the EU/EEA, affected age-groups, transmissibility and severity. The overall impact of the disease epidemiology at population level, including reinfection and effect on vaccination, and the longer term evolution of the variants and emergence of new variants is also unknown. Epidemiological and phylodynamic analyses, together with antigenic and genetic characterisation analyses, are urgently needed on an ongoing basis
Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update
Risk assessment
21 Jan 2021
This risk assessment presents the latest available information on the recent emergence of three variants of concern, VOC 202012/01 identified in the United Kingdom (UK), 501Y.V2 identified in South Africa, and P.1 identified in Brazil and Japan.
Executive summary
Viruses constantly change through mutation and variations in the SARS-CoV-2 virus, due to evolution and adaptation processes, have been observed worldwide. While most emerging mutations will not have a significant impact on the spread of the virus, some mutations or combinations of mutations may provide the virus with a selective advantage, such as increased transmissibility or the ability to evade the host immune response. In this update we report new information on the spread of three virus variants (VOC 202012/01, 501Y.V2 and variant P.1). These variants are considered to be of concern because of mutations which have led to increased transmissibility and deteriorating epidemiological situations in the areas where they have recently become established.
Based on the new information, the risk associated with the introduction and community spread of variants of concern has been increased to high/very high and the options for response have been adjusted to the current situation.
Variants of concern
VOC 202012/01 was first identified as being of concern in the south of the United Kingdom (UK) in December 2020. The first sample in which it could be identified has been traced back to September 2020. Since then, it has become the predominant variant circulating in the UK. It is characterised by a significantly increased transmissibility, which has contributed to increases in incidence, hospitalisations and pressure on the healthcare system since the second half of December 2020. The UK has implemented stricter non-pharmaceutical interventions (NPIs) to reduce transmission. Preliminary studies indicate that there is no evidence that VOC 202012/01 is associated with a significantly different infection severity or that it disproportionally affects certain age groups more than the previous circulating viruses. However, as a result of the increased incidence, by January 2021 the UK had reported the highest daily COVID-19 mortality since the start of the pandemic. Ireland, where local circulation of VOC 202012/01 has also recently been identified, has experienced an increase in case numbers and hospitalisations, growing pressure on the health system and has also had to implement stricter NPIs. Denmark has also observed community transmission of VOC 202012/01 and in response has strengthened NPIs and prolonged measures throughout January 2021.
The variant 501Y.V2 was first identified in South Africa in December 2020, where it is now the most prevalent variant. Preliminary results indicate that this variant may also have an increased transmissibility. However, as for VOC 202012/01, at this stage it is uncertain whether the 501Y.V2 variant causes a change in disease severity. As per 19 January 2021, 501Y.V2 has been identified in 10 EU/EEA countries. One cluster of this variant is currently being investigated in France. In addition to France, Israel and the UK have also reported cases or clusters of non-travel-related 501Y.V2 cases. The remaining cases identified in the EU/EEA have mostly been travel-related, but not only from South Africa.
The P.1 variant has so far only been identified in Brazil, and in travellers from Brazil (mostly from the Amazonas State) reported in Japan and South Korea. The capital of Amazonas, Manaus, is currently experiencing an upsurge in COVID-19 cases, putting significant pressure on the healthcare system.
The under-ascertainment of SARS-CoV-2 infections in general, and the very small proportion of cases undergoing sequencing in most EU/EEA countries, may lead to a large under-ascertainment of the true number of VOC 202012/01, 501Y.V2 and P.1 infections, and other potential variants that may contribute to rapid epidemiological changes.
Risks associated with virus variants
ECDC assesses the probability of the introduction and community spread of variants of concern in the EU/EEA as very high due to their increased transmissibility. Such an increased transmissibility is likely to lead to an increased number of infections. This, in turn, is likely to lead to higher hospitalisation and death rates across all age-groups, but particularly for those in older age groups or with co-morbidities. Consequently, stricter NPIs are needed to reduce transmission and relieve the pressure on healthcare systems. Therefore, the impact of introduction and community spread is considered to be high. The overall risk associated with the introduction and community spread of variants of concern is therefore assessed as being high/very high.
Options for response
Member States should continue to monitor local changes in transmission rates or infection severity to identify and assess the circulation and impact of variants. In order to detect introductions of known variants, as well as the emergence of new variants, Member States need to increase the level of surveillance and sequencing of a representative sample of community COVID-19 cases.
Member States should prepare laboratories for increased testing turnover. Laboratories should consider implementing diagnostic pre-screening for variants of concern (e.g. N501Y and deletion 69-70), ensure resources are available to manage an increasing number of requests for detection and characterisation of COVID-19 samples, and increase sequencing capacity by making use of all possible sequencing capacity from clinical, diagnostic, academic and commercial laboratories across different sectors.
In order to control the spread and impact of the SARS-CoV-2 emerging variants with increased transmissibility, a combination of compliance with NPIs – including potentially stricter NPIs than those currently in place – and strengthened case detection with contact tracing is required. Since the population groups driving transmission will not be targeted with vaccination for some months, Member States are recommended to be very cautious about relaxing NPIs. Furthermore, in light of the evidence of substantially higher transmissibility of the new variants of concern, national authorities should rather be ready to enforce even stricter measures, communicating and engaging with the population to encourage compliance. In general, contact tracing should be reinforced, and its scope widened in relation to cases suspected to be infected with new variants.
In order to slow down the importation and spread of the new SARS-CoV-2 variants of concern, ECDC recommends that non-essential travel should be avoided. In addition to recommendations against non-essential travel, and restrictions on travel for those infected, travel measures such as the testing and quarantining of travellers should be maintained, in particular for travellers from areas with a higher incidence of the new variants. If sequencing is inadequate to exclude the possibility of a higher incidence of the new variants, as per ECDC guidance on genomic sequencing, proportionate travel measures should also be considered from areas where there is a continued high level of community transmission.
Member States should prepare their healthcare systems for a further escalation in demand due to the increased transmissibility of the new variants of concern.
Member States are encouraged to accelerate the pace of vaccination for high-risk groups, such as the elderly and healthcare workers. At this stage, vaccination should be focused on protecting those most at risk from severe disease, and reducing morbidity, mortality and the burden on healthcare systems. It is important to use the available vaccines to provide protection for those who are most vulnerable and for key workers against the current circulating virus variants in the EU/EEA, and hopefully also against one or all of the new variants of concern. Assessment of VOC 202012/01 suggests cross-immunity is present, while investigations into the other variants of concern are still on-going. Member States should monitor vaccine effectiveness for these new variants. Breakthrough infections should be monitored, carefully investigated (including sequencing the virus variant causing breakthrough infection), and reported to public health and regulatory agencies to allow for an overview at country and EU-level. In addition, Member States should explore options for optimal use of the limited number of vaccine doses.
European Centre for Disease Prevention and Control. Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA, first update – 21 January 2021. ECDC: Stockholm; 2021.
Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update – EN – [PDF-1.46 MB]
While these are the three highest profile variants currently on our radar, there are almost daily reports coming in from around the globe of new variants that have yet to be explored. Most will prove inconsequential, but COVID continues to evolve and adapt, and additional VOCs (Variants of Concern) are likely to emerge over time.

An anonymous reader quotes a report from Electrek: The DMC DeLorean has been out of production for almost 40 years, but now we’ve learned that the iconic vehicle might be coming back as an electric car. In 1995, Stephen Wynne bought the company’s old inventory and trademark to relaunch the brand based in Texas. At first, the plan was to bring back the same vehicle with more modern technology in low volume. For the past 5 years, the company pushed for the adoption of new rules for low volume vehicle production with the National Highway Traffic Safety Administration (NHTSA). These new rules were finally recently adopted, but the delay was so long that it complicated DeLorean’s plans. The engine that they plan to use is not going to be compliant with emission standards starting in 2022 and the landscape has changed significantly.
In a new blog post, the company is now hinting that going electric with the DeLorean: “That said, with EV’s becoming more mainstream, we’ve been considering switching to an all-electric as the future. It certainly makes for an easier path through emissions maze which still looms large over any internal combustion engine. While an electric Cobra or Morgan may be a little extreme for their potential market, we’ve already seen that an EV DeLorean — as we displayed at the 2012 New York International Auto Show — is not such an ‘out there’ idea.” The company hints at being in the process of looking to secure financing to bring an electric DeLorean and says “stay tuned.”
Read more of this story at Slashdot.

Following widespread reports of police officers issuing warnings to opposition figures and activists across Russia, law enforcement officials in Moscow have arrested several of Alexey Navalny’s closest associates. This comes ahead of countrywide protests opposing his detention planned for Saturday, January 23. On the evening of January 21, police detained the opposition figure’s press secretary, Kira Yarmysh, as well as Anti-Corruption Foundation employees Lyubov Sobol, Georgy Alburov, and Vladlen Los. Similar arrests have also been reported in three other cities so far.
"Luce di parole, ombra di sogni."
Living on the Edge of the Sagebrush Ocean
Spiritual Insights & Personal Empowerment
Love life
Artist & Art Blogger
Furnicraft, woodwork, and art
reveries and rants
Bem Vindos a este espaço onde compartilhamos um pouco da realidade do Japão à todos aqueles que desejam visitar ou morar no Japão. Aqui neste espaço, mostramos a realidade do Japão e dos imigrantes. O nosso compromisso é com a realidade. Fique por dentro do noticiário dos principais jornais japoneses, tutoriais de Faça você mesmo no Japão e acompanhe a Série Histórias de Imigrantes no Japão. Esperamos que goste de nossos conteúdos, deixe seu like, seu comentário, compartilhe e nos ajudar você e à outras pessoas. Grande abraço, gratidão e volte sempre!
Willkommen auf Elke´s Glücks-Blog
- Specializing in the great outdoors, capturing nature at its finest!
A site to discuss education and democracy
Seu Guia de Inspirações e Reflexões Diárias
my-health-and-beauty.com/
Benim Gezegenime Hoş geldiniz !!!
Blog de viajes y lugares
The official blog of Ed Mooney Photography. Dad of 3, Photographer, Blogger, Powerlifter. Exploring the historical sites of Ireland.
It has new aidias,news, about education , motivation, social, historical, culture, marketing creation new aidias education of language science culture and history
L'unico modo sensato di vivere è senza regole
by Anuran (A) & Sayoni (S)
Fun for the Brain
An exemplary learning community.
Loves, lamentation, and life through prose, stories, passions, and essays.
public tantrums by a non-two-year-old
Public, street and urban art worldwide
all the rules of free form
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-2937106805202763" crossorigin="anonymous"></script>
Lapsed Painter, Occasional Photographer, Compulsive Writer
Health Blogs
Exploring the hidden architectural heritage of Budapest
Yaşamdan
The third incarnation...
More than a thought less than a question
"بوصلة الحياة: مدونة متعددة المجالات، من السياسة إلى الرومانسية، ومن تطوير الذات إلى الأدب وأكثر!" بقلم مشاعر بنت عبدالرحمن
The view from here ... Or here!
Bringer and seeker of joy
The One Where She Stumbled Through Her 40's and Faced Her Demons
Baw wit da baw. Just sayin'.
Website storys
Welcome to the Anglo Swiss World
Querbeet und ohne Gewähr
KINDNESS IS FREE, sprinkle it all over the world, and 😁 smile
Nuestra ética de todos los días...
Fiction Writer in Poet's Clothing
You must be logged in to post a comment.